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Recruitment of renal tubular epithelial cells expressing vero- dence of renal diseases has been noted in human immu-
toxin-1 (Stx1) receptors in HIV-1 transgenic mice with renal nodeficiency virus (HIV)-infected patients [1–3]. Among
disease. these renal parenchymal diseases, HIV-infected childrenBackground. Human immunodeficiency virus (HIV)-infected
may develop hemolytic uremic syndrome (HUS) andchildren are at risk of developing several renal parenchymal
diseases, including hemolytic uremic syndrome (HUS). HUS thrombotic thrombocytopenic purpura [4–7]. HUS is a
is most frequently caused by infection with enteric Escherichia frequent cause of acute renal failure in children and is
coli producing Shiga-like toxins (Stxs). In vitro studies have
characterized by hemolytic anemia, thrombocytopenia,shown that cytokines known to be present at high systemic
and microangiopathic lesions within the glomeruli [8–levels in HIV-1–infected children up-regulate the expression
of the Stx glycolipid receptor (Gb3) in cultured endothelial 10]. HUS may be caused by infectious agents, malignan-
cells. Thus, we studied whether HIV-1 or the HIV-associated cies, drugs, systemic infections, or congenital diseases in
“cytokine milieu” could modulate the expression of renal Stxs
infants, older children, and adults [9, 10]. More typically,receptors in vivo.
HUS is primarily associated with a diarrhea syndromeMethods. We used HIV-1 transgenic mice (HIV-Tg) ex-
pressing a deletion mutant of HIV-1 (pNL4–3). These mice caused by Shiga-like toxins (Stxs) producing E. coli in
develop renal disease similar to that of HIV-1–infected children. children [11, 12].
The expression of Gb3 was studied in renal sections from control Shiga-like toxins specifically recognize the glycosphin-and HIV-Tg mice by histochemistry, thin layer chromatogra-
golipid globotriaosyl ceramide (galactose a1-4galactosephy overlay studies, and high-pressure liquid chromatography.
Results. By histochemistry, we found a significant recruit- b1-4glucosyl ceramide-Gb3) [13, 14], which is located on
ment of renal tubular epithelial cells expressing Gb3 in HIV- the plasma membrane of renal glomerular endothelial,
Tg mice with nephropathy, whereas kidneys from control mice
mesangial, and tubular epithelial cells [15–18]. Bindingshowed limited staining in renal tubules. Gb3 was not found
of Stxs to Gb3 is the primary determinant of its cytotoxicin glomeruli of either control or HIV-Tg mice. Thin layer
chromatography overlay studies with Stxs and high-pressure effects [13, 19–21] and results in toxin internalization to
liquid chromatography studies confirmed the marked elevation initiate cell killing. Stxs promote leukocyte adhesion toof Gb3 in HIV-Tg kidneys with renal disease.
endothelial cells [22] and induce the production of in-Conclusions. These results suggest that the presence of HIV-
associated nephropathy is associated with the recruitment of renal flammatory cytokines by endothelial [20–23] cells or
tubular epithelial cells expressing Stx1 receptors. The up-regula- macrophages [24], and vice versa, cytokines can potenti-
tion of Stx1 receptors in HIV-diseased kidneys may increase ate Stxs cytopathology by up-regulation of Gb3 [25, 26].the sensitivity of these cells to the cytotoxic effects of Stxs.
Thus, it is possible that changes in Gb3 may increase the
sensitivity of HIV-1–infected children to develop HUS.
HIV-1 infected children have high systemic levels ofSince the early years of the acquired immunodefi-
inflammatory cytokines [27–29]. Interleukin-1b and tu-ciency syndrome (AIDS) epidemic, an increased inci-
mor necrosis factor-a (TNF-a) up-regulate the expres-
sion of Gb3 in cultured human umbilical vein endothelialKey words: HIV nephropathy, hemolytic uremic syndrome, Shiga-like
toxin receptors, cytotoxin, epithelial cells. cells [20, 26]. On the other hand, the high expression of
Gb3 in cultured human renal glomerular microvascularReceived for publication April 20, 1998
cells cannot be stimulated further by cytokines in vitroand in revised form September 4, 1998
Accepted for publication September 8, 1998 [23]. Thus, it is not clear how the HIV-1–associated “cy-
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in vivo. To determine whether HIV-1 and/or the HIV- the receptor glycolipid Gb3, which contains a terminal
a-galactose residue, control and transgenic renal sectionsassociated “cytokine milieu” could modulate the expres-
sion of renal Gb3 in vivo, we used transgenic mice ex- were pretreated overnight with 1 U/ml a-galactosidase
(Sigma, St. Louis, MO, USA) and were then exposed topressing a deletion mutant of HIV-1 (pNL4-3) [30, 31].
These mice develop a cytokine profile and renal disease FITC-labeled Stx1 B. The staining was compared for
sections with or without a-galactosidase pretreatment.that are clinically similar to that of children infected with
HIV-1 [30–33], even if they are not exposed to Stxs. The intensity and distribution of Gb3 in renal glomeruli,
cortex, and medulla were estimated in five different mi-Histologically, the kidneys are enlarged, and there is evi-
dence of glomerulosclerosis, severe microcystic tubular croscopic fields (310) in each renal section from five
mice in each group. The number of glomeruli or tubulesdilation, and increased levels of cytokines and HIV genes
in renal tissues [31–33]. In this study, we demonstrate showing positive staining was counted. Results were ex-
pressed as a percentage of positive structures from allrecruitment of renal tubular epithelial cells (RTEcs) ex-
pressing Gb3 in HIV-1 transgenic mice with renal disease. glomerular or tubular structures examined in each sec-
tion and were scored as negative (score 0, , 2.5%), 11These findings suggest that the presence of HIV-associ-
ated nephropathy may potentiate the renal cytotoxic ef- (score 1, 2.5% to 25%), and 21 (score 2, . 26%).
fects of Stxs.
Immunostaining of Gb3
Gb3 was detected by indirect immunohistochemistry.METHODS
Briefly, frozen sections were fixed with 2% paraformalde-
Transgenic mice hyde for 10 minutes at 48C, rinsed in phosphate-buffered
saline (PBS) for five minutes, and then blocked in 1%We used HIV-1 transgenic mice expressing a deletion
mutant of HIV-1 (pNL4-3) and normal littermate control bovine serum albumin (fraction V; Sigma) PBS for 30
minutes. The specificity of the anti-Gb3 rat IgM mono-mice. This transgenic mouse model (HIV-Tg26) has been
described in detail in previous publications [30, 31]. Con- clonal antibody was previously described [34]. Tissue sec-
tions were incubated overnight with the primary antibodytrol and heterozygous HIV-Tg26 mice were followed
from birth and sacrificed by cervical dislocation at approxi- (1:400 in PBS) at 48C. A m-chain specific biotinylated-
rabbit antirat IgM (Zymed, San Francisco, CA, USA)mately 10, 25, and 45 days of life. A total of five control
and five transgenic mice was sacrificed at each time pe- was used as secondary antibody (0.4 mg/ml, 1:200 in PBS).
Binding of the secondary antibody was detected withriod in two different experiments. This time course was
selected based on the natural course of the renal disease alkaline phosphatase-conjugate streptavidin (1 mg/ml,
1:500 in PBS; Boehringer Mannheim, Mannheim, Ger-in transgenic mice [31, 32]. Briefly, heterozygous trans-
genic mice are born without renal disease and develop many) and developed with fast red substrate solution
(Boehringer Mannheim). Sections were counterstainedprogressive nephropathy. Ten-day-old HIV-Tg mice do
not reveal differences in renal histology or clinical evi- with hematoxylin and examined under light microscopy.
Controls included replacing the primary antibody withdence of renal disease. At approximately 20 days of age,
proteinuria begins, in association with renal glomerular equivalent concentrations of an irrelevant rat IgM anti-
body or by omitting the first antibody. Sections wereand tubular injury and high levels of HIV-1 gene expres-
sion in renal epithelial cells [31–33]. Finally, at approxi- observed under light microscopy, and results were quan-
titated by counting the number of renal structures withmately 35 to 60 days of life, mice develop glomeruloscle-
rosis and renal microcystic changes in association with positive Gb3 staining as described earlier here. Cells ex-
pressing Gb3 were characterized by immunohistochemis-the highest levels of tissue cytokines, but low levels of
HIV gene expression in renal tubules [31, 32]. The kid- try studies using antibodies against the following: factor
VIII, vimentin, cytokeratin, a KP1 human CD68, leuko-neys from control and transgenic mice were immediately
removed and frozen in isopentane on dry ice for immu- cyte common antigen (Dako, Glostrup, Denmark), and
smooth muscle a-actin (Sigma). The staining distributionnohistochemistry and Stx1 binding studies. Urine and
blood samples were collected for analysis of urinary pro- was evaluated as described earlier here. To localize the
Gb3 staining more precisely, we did colocalization histo-tein and creatinine and blood urea nitrogen (BUN) and
plasma creatinine. These parameters were measured fol- chemistry studies with lectins that could discriminate the
various nephron segments. Double staining of Gb3 andlowing standard methods as previously described [31].
lectins or Gb3 and cytokeratin were done with the Histo-
Shiga-like toxin-1 (VT-1) binding studies stain-DSe double staining kit (Zymed). A biotinylated
rabbit anti-rat IgM was used as a second antibody forFluorescent Stx1 binding studies were performed on
5 mm frozen renal sections using FITC-labeled Stx1 B the Gb3 staining. Biotinylated forms of Dolichos biflorus
agglutinin, Peanut agglutinin, and Lotus tetragonolobussubunit as previously described [15, 16]. To establish that
the binding specificity corresponded to the presence of agglutinin (50 to 80 mg/ml) from Vector Laboratories
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(Burlingame, CA, USA) were used to identify collecting were pretreated overnight with 1 U/ml a-galactosidase
and then exposed to FITC-labeled Stx1 B (Fig. 1B). Theducts, distal tubules, and proximal tubules, respectively
[35–37]. recruitment of Stx receptors in renal tubules from HIV-
Tg mice with renal disease correlated with the presence
Lipid extraction and toxin thin layer chromatogram of proteinuria and azotemia. Urinary protein/creatinine
overlay studies ratios in control and HIV-Tg mice were control 8.5 6
0.8 vs. HIV-Tg 51 6 6.6. Plasma BUN levels were controlLipids were extracted from two control and two dis-
23 6 1.5 vs. HIV-Tg 43 6 4.8 mg/dl, and plasma creati-eased transgenic kidneys and the neutral glycolipid frac-
nine values were control 0.45 6 0.0016 vs. HIV-Tg 0.6tion prepared by silicic acid chromatography [15].
6 0.09 mg/dl (mean 6 sem, N 5 5, P , 0.05, for all
High-pressure liquid chromatography groups, respectively).
The Gb3 concentration in the mouse kidney extracts
Localization of Gb3was quantitated by normal-phase high-pressure liquid
Immunohistochemistry studies confirmed the resultschromatography (HPLC) after benzoylation, and inte-
of the Stx1 binding studies. Gb3 was localized on RTEcsgration relative to an internal galactosyl glycerol stan-
in the renal cortex and medulla (Fig. 1F). The highestdard [15].
level of Gb3 expression was detected in collecting ducts
Statistical analyses and distal tubules in the renal medulla. No staining was
detected in renal glomeruli from control or HIV-Tg mice.Results are expressed as the mean 6 sem of values
Diseased kidneys from HIV-Tg mice showed a signifi-obtained from at least two different experiments. For
cant recruitment of RTEcs expressing Gb3 in the renalstatistical analysis, scores of 0 were given an arbitrary
cortex and medulla (Fig. 1E). Renal tubules undergoingvalue of 0.1. Differences between groups were compared
injury and regenerative changes were more significantlyby Student’s t-test. P values of less than 0.05 were consid-
stained (Fig. 1 G, H). Transgenic mice of similar ageered significant. When more than two means were com-
(more than 45 days) but without renal disease did notpared, significance was determined by one-way analysis
show recruitment of RTEcs expressing Gb3, suggestingof variance followed by multiple comparison using the
that these changes were related to the renal disease andStudent-Neuman-Keul’s test.
not the aging process. Finally, no significant differences
in Gb3 expression were detected between young controls
RESULTS (less than 25-day-old mice) and young transgenic mice
Verotoxin binding in control and transgenic (less than 25-day-old mice) without renal disease (data
mouse kidneys not shown). Both groups showed average staining scores
of 1 (P . 0.05).As shown in Figure 1, renal glomeruli from control
and HIV-1 transgenic mouse kidneys did not bind FITC-
Quantitation of Gb3 expressionlabeled VT-1 (Stx1; score 0). In control kidneys, Stx1
Toxin/thin layer chromatography (TLC) overlay stud-staining was limited to tubular collecting ducts, distal
ies and Gb3 quantitation supported our histochemicaltubules, few proximal tubules, and interstitial cells (aver-
results. Aliquots of the glycolipid fraction equivalent toage score 1; Fig. 1D). HIV transgenic diseased kidneys
4 mg tissue were separated by TLC and were tested forshowed binding in similar areas, in addition to significant
Stx binding by toxin overlay [15]. Gb3 was detectable inrecruitment of RTEcs expressing Stx1 receptors in di-
the normal mouse kidney fractions (Fig. 2, lanes A andlated collecting ducts and distal tubules located in the
B). However, toxin binding was significantly increasedrenal cortex and medulla (average score 2, P , 0.05; Fig.
in Gb3 in the extracts of both the HIV transgenic kidneys1A–C). Stx1 binding to renal tubules was significantly
decreased when renal sections from control or Tg mice (Fig. 2, lanes C and D). The doublet characteristic of
c
Fig. 1. Verotoxin-1 (Stx1) binding and immunohistochemistry Gb3 staining in control and HIV transgenic mice. (A–D) Fluorescent staining using
FITC-labeled Stx 1 in control (D) and HIV transgenic kidneys (A and C). In control kidneys, Stx1 staining was predominately localized to renal
collecting ducts and distal tubules. HIV transgenic mice showed a significant recruitment of Stx1 binding sites in RTEcs. (B) A transgenic renal
section pretreated overnight with 1 U/ml a-galactosidase and then incubated with FITC-labeled Stx1, as described in the Methods section. As
expected, Stx1 staining was significantly reduced. (E and F ) Immunohistochemistry staining with an anti-Gb3 monoclonal antibody in control (F )
and HIV transgenic (E ) kidneys. Similar staining patterns were found for both anti-Gb3 and Stx1 staining. Note the significant recruitment of
RTEcs expressing Gb3 in HIV transgenic mouse kidneys (E). As shown in panels G and H, Gb3 (red) was predominately localized to dilated
collecting ducts and distal tubules in HIV-Tg mice with renal disease (costained blue with the lectin peanut agglutinin). (Magnification: A, B, C,
and G 3200; D, E, and F 3100, H 3500)
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Table 1. Glycosphingolipids (GSL) levels of control and HIV
transgenic diseased mouse kidneys
GL-2 Gb3 Gb3
KIDNEYS GC (Gb2 1 LC) upper band lower band Gb4
Control A 36 85 13 81 128
Control B 30 87 14 82 134
HIV–Tg A 88 189 60 150 202
HIV–Tg B 99 98 14 103 144
Values represent pmol of GSL/mg tissue. A total of 4 mg was run for the
TLC overlay.
Abbreviations are: HIV–Tg, HIV–transgenic kidney; GC, galactosyl ceramide;
GL-2, glycolipids (galabiosylceramide[Gb2] 1 lactosylceramide); Gb3, globotri-
aosylceramide, upper and lower (hydroxylated) bands; Gb4, globotetraosylcera-
mide.
to control. These findings suggest the possibility that
HIV-1–infected children infected by enteric E. coli-pro-
ducing Stxs may be at higher risk of developing renal
tubular injury. Recent studies have suggested that RTEcs
may be more sensitive to the effect of Stxs than endothe-
lial cells [18]. Thus, it is possible that HIV-1–infected
Fig. 2. Detection of Gb3 in control and HIV transgenic kidneys. VT-1 children exposed to enteric bacteria-producing Stxs may
(Stx1) thin layer chromatography (TLC) overlay studies were per- undergo significant renal tubular injury, even withoutformed with lipids extracts from control and transgenic diseased kidneys
clinical evidence of microangiopathic hemolytic anemia.(4 mg of tissue from each kidney). Lanes A and B show control kidneys;
lanes C and D show transgenic kidneys; lanes E and F show Gb3 and The distribution of VT-binding sites in normal mice
Gb2 standards. The Gb2 standard (upper bands in E and F) is from a is consistent with the results of previous studies [15, 16].marine sponge and does not line up well with the mammalian Gb2
Renal glomeruli from control and transgenic mice did(detected in lane C upper band). Abbreviations are: GC, galactosyl
ceramide; LC, lactosylceramide; Gb2, galabiosylceramide; Gb3, globotri- not express detectable levels of Gb3. Binding of FITC-
aosylceramide; Gb4, globotetraosylceramide. labeled Stx1 was predominately, but not exclusively, lo-
calized to renal collecting ducts and distal tubules, and
the majority of Gb3 in normal mice were detected in the
renal medulla. These findings correlate with the resultsthe heterogeneity of the Gb3 hydrocarbon chains was
of Lindgren, Melton and O’Brian [40], who showed thatevident in one sample (D), whereas the other (C) con-
tubules in the renal medulla were more significantly in-tained a galabiosyl ceramide (gal a1-4 gal ceramide-Gb2)
jured when mice were fed bacteria-producing Stxs. Todoublet in addition to Gb3. Both Gb3 and Gb2 are func-
our knowledge, this is the first study demonstrating ational receptors for Shiga-like toxins [38]. HPLC con-
remarkable recruitment of Stx binding sites in HIVfirmed the increased Gb3 content of the transgenic kidneys
transgenic mouse kidneys. Moreover, a similar recruit-(Table 1). Thus, the Stx receptor glycolipids were mark-
ment of Stx binding sites has not been reported in anyedly elevated in the transgenic mice with renal disease.
other animal model. These findings strongly suggest that
HIV-1 transgenic mice may be more sensitive to the
DISCUSSION action of Stx1.
One mechanism or several mechanisms can be envi-Renal damage caused by Stxs seems to be directly
related to the systemic absorption of the toxin from the sioned to explain the recruitment of Gb3 found in RTEcs
from HIV-1 transgenic mice with renal disease. First, thegastrointestinal tract [11, 39], which then binds Gb3 glyco-
lipid located on the surface renal cells. Toxin-binding expression of Gb3 may be up-regulated by HIV-1 or
by the expression of HIV gene products. However, thesites have been demonstrated within pediatric glomeruli
(but not adult) [16] and on pediatric mesangial cells changes in HIV-1 gene expression in RTEcs from
transgenic mice did not correlate with the expression of[17]. Stx binding sites within the epithelial cells of renal
tubules and collecting ducts have been found, irrespec- Gb3, as no differences in Gb3 expression were found in
young transgenic mice at their highest peak of HIV genetive of age [16, 18]. An altered distribution of Gb3 in
renal glomeruli and tubules of HIV-1–infected children expression [31, 32]. Alternatively, because both Gb3 and
Gb2 were elevated in the transgenic mouse kidneys, it ismay increase their risk of developing renal injury follow-
ing gastrointestinal Stx E. coli infection. In this study, possible that the transgene has activated the a-galactosyl
transferase, which is the enzyme responsible for the syn-we have shown that RTEcs from HIV-1 transgenic mice
with renal disease show elevated Gb3 expression relative thesis of both these glycolipids. Gb3 and Gb2 have been
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implicated in the mechanism of a2 interferon signal recruitment of RTEcs expressing high levels of Gb3 is
transduction [41, 42]. Both a2-interferon and CD19 a specific pathogenic feature of HIV nephropathy in
share sequence similarity with the Stx1 (VT-1) B subunit humans. In summary, it is possible that a combination
[41–43]. Cell surface Gb3 undergoes a process of “retro- of factors, that is, the release of cytokines known to
grade transport” to the Golgi [44], endoplasmic reticu- stimulate the cycling and regeneration of RTEc [32], in
lum, and nucleus [45], which is crucial for CD19 signaling addition to other HIV-1 cofactors not well understood
[46]. Thus, the up-regulation of the synthesis of Gb3 and at this time, may explain the high levels of Gb3 found in
Gb2 may relate to the induction of interferon by HIV or HIV transgenic mice with renal disease.
to the transgene gene product gp120 [47–49]. In addition, These findings may be clinically relevant in the patho-
several in vitro studies support the hypothesis that cyto- genesis of HIVAN and other HIV-infected tissues as
kines can up-regulate the expression of Gb3 in renal well. Gb3 is a human B-cell glycolipid differentiation
cells [20, 25, 26]. In this regard, there is an excellent antigen (CD77), which is specifically expressed on a sub-
correlation between the renal peritubular accumulation set of tonsillar B-lymphocytes located in germinal centers
of basic fibroblast growth factor [32] and TGF-b1 [50], of lymphoid tissue [59–62]. Stx1 treatment of human
and the recruitment of Gb3 in renal tubules from HIV lymphoid cells diminishes B-cell responses in vitro and
transgenic mice with renal disease. Both cytokines also induces apoptosis in IgG committed cells [63, 64], sug-
modulate renal tubular epithelial cell growth and differ- gesting that humoral immunity may be affected during
entiation. Additional studies will be required to deter- the acute stages of infection with enteric bacteria produc-
mine whether other cytokines known to modulate the ing Stxs [43, 61–63]. Thus, it is tempting to speculate that
expression of Gb3 in endothelial cells, that is, TNF-a, the Gb3 may have an additional immunosuppressive role
interleukin-1b, and interferon g, may have a similar role in HIV-infected children and that similar changes in Gb3
in RTEcs, and to define whether these cytokines are may be present in lymphoid tissues as well. On the other
accumulated in HIV-Tg diseased kidneys. hand, these results should be interpreted with caution.
Alternatively, other factors in addition to the cytokine The response of cultured endothelial cells to purified
profile may modulate the expression of Gb3 in RTEcs. verotoxin is variable [23, 26], and studies using the pig
An increase in the fraction of cycling RTEcs following animal model showed that some toxin binding sites are
HIV-induced renal tubular injury may also contribute resistant to the action of the toxin [65]. Moreover, the
to up-regulate the synthesis of Gb3 in HIV transgenic total number of renal Gb3 receptors is significantly in-mice with renal disease [51]. The recruitment of RTEc creased in adult human kidneys [15, 16], but adults do
expressing Gb3 was mainly localized to renal tubules not typically develop renal injury when exposed to Stxs.undergoing tubular microcystic changes and proliferat-
It is possible that adults may develop an immune re-ing epithelial cells. The fact that some of these cells
sponse to bacteria producing Stxs and that they may beexpress vimentin, a fibroblast marker also expressed by
protected. In contrast, HIV-infected children are usuallyregenerating RTEcs [52], supports this hypothesis. Thus,
exposed to many risk factors, including immunosuppres-it is tempting to speculate that Gb3 may play a role in sion, nephrotoxic drugs, and high levels of circulatingcells undergoing epithelial-mesenchymal differentiation
cytokines. Thus, a combination of all of these factorschanges during renal tubular regeneration. Gb3 expres- may potentiate the pathogenic effects of Stxs on HIV-sion is increased in the logarithmic, as opposed to the
infected children.stationary growth phase of the cell cycle [43, 51]. These
In conclusion, we have found a significant recruitmentchanges are not restricted to epithelial cells from HIV-
of Gb3 in RTEcs in HIV-1 transgenic mice with renalinfected kidneys with renal disease. Similar findings were
disease. These findings suggest the possibility that HIV-found in epithelial cells from certain human tumors [53,
infected children exposed to enteric bacteria producing54]. Neoplastic cells from primary ovarian tumors and
Stxs may be at higher risk of developing severe renalmetastases contain elevated levels of Gb3, and VT bind-
tubular injury. A prospective clinical trial in HIV-infecteding sites are selectively up-regulated in the lumen of
children exposed to Stxs will be required to test thisblood vessels invading the tumor [55, 56]. These cells
hypothesis.are also hypersensitive to verotoxin effects [56]. On the
other hand, not all rapidly proliferating RTEcs express
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